Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration

International Journal of Cardiology

Volumn 86, Issue 2-3, 2002, Pages 225-231

  Kalra, Paul R ^a   Sharma, Rakesh ^a   Shamim, Waqar ^a   Doehner, Wolfram ^a,b   Wensel, Roland ^a   Bolger, Aidan P ^a   Genth Zotz, Sabine ^a   Cicoira, Mariantonietta ^a   Coats, Andrew J S ^a   Anker, Stefan D ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RISK ASSESSMENT; SURVIVAL;

AGED; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS;

EID: 0036888561     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00270-X     Document Type: Article

References (28)

1. Kelly D. Paul Dudley White International Lecture. Our future society. A global challenge. Circulation. 95:1997;2459-2464.
2. McMurray J., McDonagh T., Morrison C.E., Dargie H.J. Trends in hospitalisation for heart failure in Scotland 1980-1990. Eur Heart J. 14:1993;1158-1162.
3. Stewart S., MacIntyre K., Hole D.J., Capewell S., McMurray J.J. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 3:2001;315-322.
4. Shamim W., Francis D.P., Yousufuddin M., et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol. 70:1999;171-178.
5. Xiao H.B., Roy C., Fujimoto S., Gibson D.G. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol. 53:1996;163-170.
6. Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New Engl J Med. 344:2001;873-880.
7. Aaronson K.D., Schwartz J.S., Chen T.M., Wong K.L., Goin J.E., Mancini D.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 95:1997;2660-2667.
8. Anker S.D., Swan J.W., Volterrani M., et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 18:1997;259-269.
9. Ponikowski P., Francis D.P., Piepoli M.F., et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation. 103:2001;967-972.
10. Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 87:1993;VI5-V16.
11. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 102:2000;3060-3067.
12. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl J Med. 311:1984;819-823.
13. Sharma R., Rauchhaus M., Ponikowski P.P., et al. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 36:2000;523-528.
14. Anker S.D., Rauchhaus M., Doehner W., et al. Uric acid and survival in chronic heart failure: validation and first attempts at metabolic, functional and haemodynamic staging. Eur Heart J (Abstract). 21:2000;1631.
15. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 349:1997;1050-1053.
16. Unverferth D.V., Magorien R.D., Moeschberger M.L., Baker P.B., Fetters J.K., Leier C.V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 54:1984;147-152.
17. Koga Y., Wada T., Toshima H., Akazawa K., Nose Y. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy. Heart Vessels. 8:1993;37-41.
18. Friedman H. Diagnostic electrocardiography and vectorcardiography. 3rd ed. 1985;McGraw-Hill, New York.
19. Braunwald E., Zipes D.P., Libby P. Heart disease: a textbook of cardiovascular medicine. 6th ed:2001;92 WB Saunders, Philadelphia, PA.
20. Selvester R.H., Velasquez D.W., Elko P.P., Cady L.D. Intraventricular conduction defect (IVCD), real or fancied, QRS duration in 1,254 normal adult white males by a multilead automated algorithm. J Electrocardiol. 23:(Suppl.):1990;118-122.
21. Pudil R., Feinberg M.S., Hod H., Boyko V., Mandelzweig L., Behar S. The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. Int J Cardiol. 78:2001;233-239.
22. Xiao H.B., Brecker S.J., Gibson D.G. Effects of abnormal activation on the time course of left ventricular pressure pulse in dilated cardiomyopathy. Br Heart J. 68:1992;403-407.
23. Grines L.C., Bashore T.M., Boudoulas H., Olson S., Shafer P., Wooley C.F. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation. 79:1989;845-853.
24. Erlebacher J.A., Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol. 88:2001;83-86.
25. Etienne Y., Mansourati J., Touiza A., et al. Evaluation of left ventricular function and mitral regurgitation during left ventricular-based pacing in patients with heart failure. Eur J Heart Fail. 3:2001;441-447.
26. Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle branch block. Circulation. 102:2000;3053-3059.
27. Barold S.S. What is cardiac resynchronization therapy? Am J Med. 111:2001;224-232.
28. Louis A., Cleland J.G., Crabbe S., et al. Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001. Eur J Heart Fail. 3:2001;381-387.